Dra. Marรญa Natalia Gandur Quiroga (@nataliagandur) 's Twitter Profile
Dra. Marรญa Natalia Gandur Quiroga

@nataliagandur

Leader GU @InstitutoRoffo #GU #RCC #prostate #bladder #testis #GUcsm #clinicaltrials #Immunotherapy #PrecisionMedicine #OncoAlert #OncoReporte
Views Mine

ID: 1001912023750529024

calendar_today30-05-2018 19:43:35

6,6K Tweet

2,2K Takipรงi

1,1K Takip Edilen

Dra. Marรญa Natalia Gandur Quiroga (@nataliagandur) 's Twitter Profile Photo
Dra. Marรญa Natalia Gandur Quiroga
@nataliagandur

10 days ago

๐ŸŒŸ๐ŸŽ“๐Ÿ‘๐Ÿงต RCC Highlights @ #ASCO25 | Part 1 ๐Ÿ’ฌ Brilliant discussion by Tian Zhang, MD, MHS on 4 pivotal studies in advanced ccRCC OncoAlert ๐Ÿ”น #Abstract4505 | CheckMate 214 โ€“ NIVO+IPI vs SUN (Marc Motzer et al) โœ”๏ธ 9-year follow-up โœ”๏ธ OS benefit in all IMDC groups โœ”๏ธ 108-mo OS: 31% vs 20%

๐ŸŒŸ๐ŸŽ“๐Ÿ‘๐Ÿงต RCC Highlights @ #ASCO25 | Part 1 ๐Ÿ’ฌ Brilliant discussion by <a href="/TiansterZhang/">Tian Zhang, MD, MHS</a> on 4 pivotal studies in advanced ccRCC <a href="/OncoAlert/">OncoAlert</a> ๐Ÿ”น #Abstract4505 | CheckMate 214 โ€“ NIVO+IPI vs SUN (<a href="/motzer/">Marc Motzer</a> et al) โœ”๏ธ 9-year follow-up โœ”๏ธ OS benefit in all IMDC groups โœ”๏ธ 108-mo OS: 31% vs 20%